What is letrozole IP 2.5 mg used for?
Letrozole tablets (IP) 2.5 mg are used to treat certain types of hormone-receptor positive breast cancer in postmenopausal women by lowering estrogen levels in the body.[1]
They may also be used in other estrogen-dependent breast cancer settings under a clinician’s guidance, depending on the stage and prior treatments.[1]
How does letrozole work in the body?
Letrozole is an aromatase inhibitor. It blocks the enzyme (aromatase) that helps produce estrogen, which can slow or stop the growth of estrogen-driven (hormone receptor-positive) breast cancers.[1]
What conditions is it commonly prescribed for?
In routine clinical use, letrozole 2.5 mg is prescribed for:
- Early breast cancer after surgery in appropriate hormone-receptor positive cases (to reduce recurrence risk)
- Advanced or metastatic hormone-receptor positive breast cancer
- Situations where estrogen suppression is part of the treatment plan (as determined by the oncology team)[1]
Who can take letrozole tablets 2.5 mg?
Letrozole is typically used in postmenopausal patients because the medicine specifically targets estrogen production pathways that matter most in that setting.[1]
If you are unsure whether it is appropriate for your menopausal status or diagnosis, your prescriber can confirm based on your pathology report (for example, ER/PR status) and treatment history.
Important patient-side safety points to know
Common issues can include symptoms related to low estrogen such as joint or muscle pain, hot flashes, and fatigue.[1]
Because letrozole affects hormone levels, it can also interact with other medical conditions and medicines. Patients should discuss:
- Current medications (including hormone therapies)
- Any history of osteoporosis or bone fractures (estrogen lowering can weaken bones)
- Pregnancy or breastfeeding plans (letrozole is generally not used in pregnancy)
If you tell me what your prescription says (diagnosis/stage, and whether it’s for adjuvant, metastatic, or neoadjuvant use), I can narrow the likely purpose more precisely.
Sources
[1] https://www.drugpatentwatch.com/